Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Globalization of clinical trials
3.2.1.2 Growing demand for outsourcing clinical trials to CROs
3.2.1.3 Rise in government and non-government funding for clinical trials
3.2.1.4 Focus on patient-centric trials
3.2.1.5 Growing technology advancements
3.2.2 Industry pitfalls & challenges
3.2.2.1 Complex and stringent regulatory requirements
3.2.2.2 Limited infrastructure in developing countries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Clinical trial volume, by region
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Diagnostic equipment
5.3 Laboratory instruments
5.4 Ancillary solutions
Chapter 6 Market Estimates and Forecast, By Service, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Rental & leasing services
6.3 Supply and logistics services
6.4 Regulatory compliance services
6.5 Software services
Chapter 7 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 Contract research organizations (CROs)
7.4 Medical device companies
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 The Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Andwin Scientific
9.2 Ancillare, LP.
9.3 AXELERIST FINANCIAL
9.4 Biocair
9.5 ICON plc
9.6 Imperial CRS, LLC.
9.7 Marken
9.8 MESM UK.
9.9 Myonex
9.10 NUVISAN
9.11 Oximio
9.12 Parexel International (MA) Corporation
9.13 Quipment SAS
9.14 Thermo Fisher Scientific Inc.
